BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $45,742,011 | +77.2% | 723,766 | +26.2% | 0.05% | +68.8% |
| Q1 2023 | $25,808,244 | +363498.8% | 573,644 | +254.0% | 0.03% | +220.0% |
| Q4 2022 | $7,098 | -100.0% | 162,029 | -54.5% | 0.01% | -71.4% |
| Q3 2022 | $23,445,000 | +15.2% | 355,817 | -11.7% | 0.04% | +25.0% |
| Q2 2022 | $20,343,000 | -52.3% | 402,742 | -39.6% | 0.03% | -41.7% |
| Q1 2022 | $42,607,000 | -62.7% | 666,992 | -37.5% | 0.05% | -57.9% |
| Q4 2021 | $114,245,000 | +19.4% | 1,066,612 | +14.6% | 0.11% | +7.5% |
| Q3 2021 | $95,718,000 | – | 931,016 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |